GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.91 $2.71 Monday, 22nd Apr 2024 CANF stock ended at $1.98. During the day the stock fluctuated 6.93% from a day low at $1.91 to a day high of $2.04.
90 days $1.91 $2.71
52 weeks $1.68 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Jan 05, 2022 $1.40 $1.40 $1.30 $1.33 751 819
Jan 04, 2022 $1.45 $1.45 $1.33 $1.39 857 415
Jan 03, 2022 $1.31 $1.45 $1.29 $1.45 1 585 860
Dec 31, 2021 $1.32 $1.38 $1.26 $1.29 1 349 950
Dec 30, 2021 $1.34 $1.39 $1.33 $1.33 1 613 384
Dec 29, 2021 $1.47 $1.47 $1.29 $1.45 19 487 213
Dec 28, 2021 $1.28 $1.31 $1.21 $1.26 1 710 182
Dec 27, 2021 $1.36 $1.36 $1.28 $1.31 1 597 821
Dec 23, 2021 $1.38 $1.47 $1.30 $1.37 2 872 294
Dec 22, 2021 $1.51 $1.51 $1.33 $1.41 4 169 582
Dec 21, 2021 $1.77 $1.79 $1.34 $1.46 21 816 472
Dec 20, 2021 $2.40 $2.60 $1.96 $2.15 167 637 947
Dec 17, 2021 $1.11 $1.28 $1.08 $1.27 254 137
Dec 16, 2021 $1.20 $1.20 $1.11 $1.13 202 267
Dec 15, 2021 $1.14 $1.22 $1.10 $1.19 212 759
Dec 14, 2021 $1.06 $1.13 $1.06 $1.13 279 963
Dec 13, 2021 $1.09 $1.10 $1.02 $1.07 323 695
Dec 10, 2021 $1.13 $1.14 $1.09 $1.10 81 386
Dec 09, 2021 $1.11 $1.19 $1.10 $1.12 229 306
Dec 08, 2021 $1.00 $1.17 $1.00 $1.11 485 945
Dec 07, 2021 $1.01 $1.02 $0.94 $0.99 490 804
Dec 06, 2021 $1.03 $1.04 $0.97 $0.98 497 063
Dec 03, 2021 $1.08 $1.09 $1.00 $1.05 221 403
Dec 02, 2021 $1.08 $1.11 $1.00 $1.06 188 532
Dec 01, 2021 $1.18 $1.21 $1.08 $1.09 188 816
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

^ false

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT